Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease.

Kathiriya IS, Rao KS, Clark AP, Hu KM, Grant ZL, Matthews MN, Chen Z, Hota SK, Saucerman JJ, Bruneau BG

DOI: 10.1242/dev.205173
Published: 2026 Jan 15
Container: Development (Cambridge, England)
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1242/dev.205173,
  title = {Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease.},
  author = {Kathiriya IS and Rao KS and Clark AP and Hu KM and Grant ZL and Matthews MN and Chen Z and Hota SK and Saucerman JJ and Bruneau BG},
  year = {2026},
  journal = {Development (Cambridge, England)},
  doi = {10.1242/dev.205173},
  url = {https://doi.org/10.1242/dev.205173}
}

RIS

TY  - JOUR
TI  - Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease.
AU  - Kathiriya IS
AU  - Rao KS
AU  - Clark AP
AU  - Hu KM
AU  - Grant ZL
AU  - Matthews MN
AU  - Chen Z
AU  - Hota SK
AU  - Saucerman JJ
AU  - Bruneau BG
PY  - 2026
JO  - Development (Cambridge, England)
DO  - 10.1242/dev.205173
UR  - https://doi.org/10.1242/dev.205173
ER  -

APA

IS, K., KS, R., AP, C., KM, H., ZL, G., MN, M., Z, C., SK, H., JJ, S., & BG, B. (2026). Reduced TBX5 dosage undermines developmental control of atrial cardiomyocyte identity in a model of human atrial disease.. Development (Cambridge, England). https://doi.org/10.1242/dev.205173

Source records

pubmed · retrieved 2026-09-25T13:19:05.603Z